Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants

Stopped CFDA announced Xi'An Risperdal as reference drug, no need for this BE trial from both scientific and ethical perspective.

Conditions

• Healthy

Interventions

• DRUG: Risperidone: Xian Risperdal (test)
• DRUG: Risperidone: Gurabo Risperdal (reference)

Sponsor

Xian-Janssen Pharmaceutical Ltd.